Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 91-100 of 220

Page
per page
  1. DAPT (GSI-IX)
    A8200 DAPT (GSI-IX)
     6 Citation
    Summary: γ-secretase inhibitor,potent and specific
      ≥21.62 mg/mL
  2. SC 144
    A2173 SC 144
     1 Citation
    Target: Glycoproteins
    Summary: Gp130 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.1 mg/mL
  3. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  4. Pimasertib (AS-703026)
    A5573 Pimasertib (AS-703026)
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.55 mg/mL
  5. Caspase-3/7 Inhibitor I
    A1925 Caspase-3/7 Inhibitor I
     2 Citation
    Target: Caspases
    Summary: Caspase-3/7 inhibitor
      insoluble in H2O; ≥16.2 mg/mL
  6. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
  7. PSI-6206
    A8189 PSI-6206
     3 Citation
    Target: HCV polymerase
    Summary: Inhibitor of HCV RNA polymerase,potent and selective
      ≥13.1 mg/mL
  8. ZM 447439
    A4113 ZM 447439
    Target: Aurora Kinases|MEK|Src|Lck
    Summary: Aurora Kinase inhibitor,potent and selective
      ≥25.7 mg/mL
  9. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  10. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL

Items 91-100 of 220

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 19item
  2. Apoptosis 19item
  3. Chromatin/Epigenetics 30item
  4. Metabolism 4item
  5. MAPK Signaling 11item
  6. Tyrosine Kinase 41item
  7. DNA Damage/DNA Repair 25item
  8. PI3K/Akt/mTOR Signaling 13item
  9. Microbiology & Virology 9item
  10. Cell Cycle/Checkpoint 37item
  11. Ubiquitination/ Proteasome 11item
  12. JAK/STAT Signaling 8item
  13. TGF-β / Smad Signaling 11item
  14. Angiogenesis 1 item
  15. GPCR/G protein 7item
  16. Stem Cell 14item
  17. Membrane Transporter/Ion Channel 7item
  18. Endocrinology and Hormones 1 item
  19. Neuroscience 3item
  20. Obesity, Appetite Control & Diabetes 1 item
  21. Others 11item
  22. Immunology/Inflammation 6item
Reversibility
  1. Reversible 21item
  2. Irreversible 6item
Target
  1. Caspases 6item
  2. Cyclin-Dependent Kinases 13item
  3. Proteasome 5item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 11item
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 1 item
  8. Bcl-2 2item
  9. PI3K 4item
  10. Raf 8item
  11. Aurora Kinases 6item
  12. Bcl-xl 1 item
  13. Glycoproteins 1 item
  14. MDM2 1 item
  15. EZH2 3item
  16. mTOR 1 item
  17. Bromodomains 1 item
  18. AP-1 3item
  19. MMP 2item
  20. Myosin II ATPases 1 item
  21. FLT3 5item
  22. GSK-3 4item
  23. LPA Receptors 1 item
  24. P-glycoprotein (P-gp) 3item
  25. PLK 3item
  26. Chk 4item
  27. Eph Receptors 1 item
  28. VEGFR 12item
  29. PDGFR 9item
  30. c-Kit 6item
  31. RET 1 item
  32. Bromodomain-containing proteins(BRDs) 1 item
  33. Phosphodiesterases (PDEs) 1 item
  34. Hydrolase 1 item
  35. Thymidylate Synthase 1 item
  36. p38 1 item
  37. Bcr-Abl 2item
  38. MEK 2item
  39. PORCN 1 item
  40. DOT1L 1 item
  41. FGFR 2item
  42. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  43. Smoothened 2item
  44. Eukaryotic elongation factors 1 item
  45. MET 5item
  46. Src 4item
  47. Trk Receptors 3item
  48. STAT 2item
  49. Microtubules/Tubulins 4item
  50. EGFR 4item
  51. Hedgehog 1 item
  52. Reverse Transcriptases 1 item
  53. ROCK 5item
  54. FAK 1 item
  55. JAK 2item
  56. p300 1 item
  57. Syk 1 item
  58. DNA-PK 1 item
  59. HSP90 1 item
  60. AMPK 2item
  61. CFTR 3item
  62. TNKS 1 item
  63. ErbB 2item
  64. Toll-like receptors (TLRs) 2item
  65. DNA Methyltransferases 1 item
  66. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  67. ERK 1 item
  68. c-MET 7item
  69. BMI-1 1 item
  70. PKC 3item
  71. HCV Proteases 1 item
  72. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  73. Lyn 1 item
  74. SGLT 1 item
  75. USP 1 item
  76. LRRK2 1 item
  77. Sphingosine kinases (SphKs) 1 item
  78. GTPases 1 item
  79. HIV-1 gp120 1 item
  80. Fatty-acid-binding proteins (FABPs) 1 item
  81. Tie-2 2item
  82. Free Fatty Acid Receptors 1 item
  83. phosphatases 1 item
  84. Autophagy 2item
  85. ATM/ATR 3item
  86. CK1 1 item
  87. Farnesyl Diphosphate Synthases 1 item
  88. Melatonin Receptors 1 item
  89. Ron 1 item
  90. Synthases/Synthetases 1 item
  91. MAGL 1 item
  92. NPY Receptors 1 item
  93. c-Fyn 1 item
  94. Histamine H1 Receptors 1 item
  95. TRP Channel 1 item
  96. Apoptosis Inducers 1 item
  97. NO Donors / Precursors 1 item
  98. IL Receptors 1 item
  99. 15-lipoxygenases 1 item
  100. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  101. Aldosterone receptor 1 item
  102. DPP-4 1 item
  103. DREADD Ligands 1 item
  104. p53-MDM2 interaction 1 item
  105. c-Fms tyrosine kinase 1 item
  106. Ub-conjugating enzyme (E2) complex 1 item
  107. HCV polymerase 2item
  108. PC-PLC 1 item
  109. DCLK2 1 item
  110. Lck 1 item
  111. Bcl-w 1 item
  112. FXR 1 item
  113. ATM 1 item
  114. Sirtuin 1 item
  115. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 196item
  2. Cell Experiments 130item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 8item
  3. Adrenocortical Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 5item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 41item
  9. Cancer 133item
  10. Cholangiocarcinoma 2item
  11. Chronic Lymphocytic Leukemia 2item
  12. Clear Cell Renal Cell Carcinoma 1 item
  13. Colon Cancer 18item
  14. Colon Carcinoma 3item
  15. Colorectal Cancer 20item
  16. Diabetes 2item
  17. Fungal Infection 1 item
  18. Glioblastoma 10item
  19. Glioma 3item
  20. HCV 2item
  21. Hepatitis C 1 item
  22. Hepatocellular Carcinoma 4item
  23. HIV 2item
  24. Immunosuppressive Therapy 1 item
  25. Inflammatory Diseases 3item
  26. Leukemia 7item
  27. Liver Cancer 3item
  28. Lung Cancer 11item
  29. Lung Carcinoma 2item
  30. Lymphoma 6item
  31. Mantle Cell Lymphoma 2item
  32. Medulloblastoma 1 item
  33. Melanoma 15item
  34. Mixed Lineage Leukemia 1 item
  35. Multiple Myeloma 8item
  36. Neuroblastoma 2item
  37. Non-small Cell Lung Cancer 7item
  38. Non-small Cell Lung Carcinoma 1 item
  39. Ovarian Cancer 13item
  40. Pain Relief 1 item
  41. Pancreatic Cancer 16item
  42. Pancreatic Carcinoma 2item
  43. Prostate Cancer 17item
  44. Psoriasis 1 item
  45. Pulmonary Fibrosis 1 item
  46. Renal Cell Carcinoma 6item
  47. Rheumatoid Arthritis 3item
  48. Sleep Disorders 1 item
  49. Thyroid Cancer 4item
  50. Type 2 Diabetes 3item